Consequently, we established BRAFi-R melanoma cell lines by gradually exposing BRAFi-sensitive HTB63 and A375 cells to increasing concentrations of two different BRAF inhibitors (PLX4032 or PLX4720). This evidence concerns the gene BRAF and melanoma.